These data suggest that miR-135a-5p is a key target of FXR activation, which causes the inhibition of the TGFBR1/TAK1 pathway, thereby resulting in the attenuation of vascular inflammation and calcification in CKD rats. This evidence concerns the gene MAP3K7 and chronic kidney disease.